🇺🇸 FDA
Patent

US 11697667

Salts and polymorphs of cethromycin for the treatment of disease

granted A61KA61K31/7048A61K31/706

Quick answer

US patent 11697667 (Salts and polymorphs of cethromycin for the treatment of disease) held by AliquantumRx, Inc. expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AliquantumRx, Inc.
Grant date
Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/7048, A61K31/706, A61P, A61P31/04